These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34626189)

  • 21. Inappropriate shocks due to subcutaneous air in a patient with a subcutaneous cardiac defibrillator.
    Zipse MM; Sauer WH; Varosy PD; Aleong RG; Nguyen DT
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):768-70. PubMed ID: 25140025
    [No Abstract]   [Full Text] [Related]  

  • 22. Complications related to elective generator replacement of the subcutaneous implantable defibrillator.
    van der Stuijt W; Quast ABE; Baalman SWE; de Wilde KC; Brouwer TF; Wilde AAM; Knops RE
    Europace; 2021 Mar; 23(3):395-399. PubMed ID: 33197266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inappropriate shock from a subcutaneous implantable cardioverter-defibrillator due to transcutaneous electrical nerve stimulation.
    Miller MA; Palaniswamy C; Sharma D; Reddy VY
    Heart Rhythm; 2015 Jul; 12(7):1702-3. PubMed ID: 25889810
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter by Gamble et al regarding article, "inappropriate shocks due to subcutaneous air in a patient with a subcutaneous cardiac defibrillator".
    Gamble JH; Grogono J; Rajappan K; Betts TR; Bashir Y; Khiani R
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1281. PubMed ID: 25516592
    [No Abstract]   [Full Text] [Related]  

  • 25. An appropriate implantable cardioverter-defibrillator shock triggering unusual phenomenons.
    Arias MA; Puchol A; Colchero T; Pachón M; Castellanos E; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1157-60. PubMed ID: 20487346
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HeartMate III Left Ventricular Assist Device Thrombosis Triggered by an Automatic Implantable Cardioverter-Defibrillator Shock.
    Klotz S; Karluss A; Stock S; Frydrychowicz A; Sievers HH
    Ann Thorac Surg; 2017 Dec; 104(6):e421-e424. PubMed ID: 29153809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks.
    Turakhia MP; Zweibel S; Swain AL; Mollenkopf SA; Reynolds MR
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):. PubMed ID: 28196927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.
    Dell'Era G; Magnani A; Occhetta E
    Europace; 2015 Nov; 17(11):1726. PubMed ID: 26462698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardio-defibrillator with an additional subcutaneous electrode shock].
    Cordeiro Piçarra B; Silva Cunha P; Oliveira M; Nogueira da Silva M; Conceição JM; Cruz Ferreira R
    Rev Port Cardiol; 2012 Apr; 31(4):321-2. PubMed ID: 22386540
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of delivered energy on defibrillation shock impedance.
    Weiss DN; Shorofsky SR; Peters RW; Gold MR
    J Interv Card Electrophysiol; 1998 Sep; 2(3):273-7. PubMed ID: 9870022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?
    Frommeyer G; Zumhagen S; Dechering DG; Larbig R; Bettin M; Löher A; Köbe J; Reinke F; Eckardt L
    J Am Heart Assoc; 2016 Mar; 5(3):e003181. PubMed ID: 27068637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event? A case report].
    Krzyzanowski K; Michałkiewicz D; Wierzbowski R; Gniłka A; Ryczek R; Orski Z; Kubik L
    Kardiol Pol; 2009 Aug; 67(8):927-9. PubMed ID: 19784895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous implantable cardioverter-defibrillators and sternal wires: a cautionary tale.
    Winter J; Kohlmeier A; Shin DI; O'Connor S
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):986-7. PubMed ID: 25336371
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
    Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB
    Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery.
    Schloss EJ; Krebs ME; Gupta M
    Heart Rhythm; 2014 Oct; 11(10):1733-4. PubMed ID: 24931635
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter-defibrillator shocks in dying patients: disturbing data from beyond the grave.
    Lampert R
    Circulation; 2014 Jan; 129(4):414-6. PubMed ID: 24243856
    [No Abstract]   [Full Text] [Related]  

  • 39. Implantable cardioverter-defibrillator shocks and their adverse impact on patient-centered outcomes: fact or fiction?
    Pedersen SS; van den Broek KC
    J Am Coll Cardiol; 2008 Sep; 52(12):1037-8; author reply 1038. PubMed ID: 18786489
    [No Abstract]   [Full Text] [Related]  

  • 40. electrical impedance monitoring has only limited effectiveness in preventing adverse clinical events, specifically inappropriate shocks, resulting from fracture of ICD leads.
    Kallis JM
    Heart Rhythm; 2009 Jan; 6(1):e5-6; author reply e6. PubMed ID: 19121788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.